Phase I trial of intranasal anthrax vaccine (AdVAV)

Trial Profile

Phase I trial of intranasal anthrax vaccine (AdVAV)

Planning
Phase of Trial: Phase I

Latest Information Update: 05 May 2017

At a glance

  • Drugs AdVAV (Primary)
  • Indications Anthrax
  • Focus Adverse reactions
  • Most Recent Events

    • 05 May 2017 According to aN Altimmune media release, this study is expected to begin during 1Q18 with data anticipated 2Q18.
    • 19 Jan 2017 According to a PharmAthene media release, this study is expected to begin during the second half of 2017 with data anticipated during the first half of 2018.
    • 24 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top